Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PRKAA2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | PRKAA2 |
| Full Name | Protein Kinase AMP-Activated Catalytic Subunit Alpha 2 |
| Aliases | AMP-Activated Protein Kinase Catalytic Subunit Alpha 2 |
| Chromosome | 1p32.2 |
| Protein Type | Serine/Threonine Kinase |
| Function | is a convergent pathomechanism across major neurodegenerative diseases, making PRKAA2 a high-priority therapeutic target. |
| Primary Expression | oligodendrocytes |
| Amino Acids | 552 aa |
| Exons | 12 |
| Pathways | Autophagy, autophagy pathway, complement cascade, oxidative stress response, phagocytosis |
| Ensembl ID | ENSG00000162409 |
| GeneCards | PRKAA2 |
| Human Protein Atlas | PRKAA2 |
| Associated Diseases | Alzheimer Disease, Neurodegeneration |
| Known Drugs/Compounds | Metformin, AICAR, rapamycin, metformin |
| Interactions | LAMP2, PLIN3, BECN1, GRK2, FOXO1, NR1H3 |
| KG Connections | 240 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
PRKAA2["PRKAA2"] -->|"interacts"| Tumor["Tumor"]
PRKAA2["PRKAA2"] -->|"interacts"| Hepatitis["Hepatitis"]
PRKAA2["PRKAA2"] -->|"activates"| Als["Als"]
PRKAA2["PRKAA2"] -->|"activates"| Ms["Ms"]
PRKAA2["PRKAA2"] -->|"interacts"| Ischemia["Ischemia"]
PRKAA2["PRKAA2"] -->|"interacts"| Inflammation["Inflammation"]
PPARA["PPARA"] -->|"interacts"| PRKAA2["PRKAA2"]
ULK1["ULK1"] -->|"interacts"| PRKAA2["PRKAA2"]
STX17["STX17"] -->|"interacts"| PRKAA2["PRKAA2"]
SQSTM1["SQSTM1"] -->|"interacts"| PRKAA2["PRKAA2"]
style PRKAA2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| protein synthesis | inhibits | process | 0.95 |
| Protein Synthesis | inhibits | process | 0.95 |
| Amino Acid Insufficiency | mediates | phenotype | 0.95 |
| Metformin | therapeutic_target | drug | 0.90 |
| Alzheimer Disease | associated_with | disease | 0.90 |
| Protein Aggregation | regulates | process | 0.90 |
| Alzheimer Disease | protects_against | disease | 0.90 |
| PPARGC1A | activates | gene | 0.85 |
| cognitive dysfunction | protects_against | phenotype | 0.80 |
| MTORC1 | inhibits | protein | 0.80 |
| Alzheimer's Disease | protects_against | disease | 0.80 |
| zonula occludens-1 | upregulates | protein | 0.75 |
| Tumor | interacts_with | disease | 0.65 |
| Hepatitis | interacts_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Ischemia | interacts_with | disease | 0.65 |
| Inflammation | interacts_with | disease | 0.65 |
| Fatty Liver | activates | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| LAMP2 | interacts_with | gene | 0.60 |
| PLIN3 | interacts_with | gene | 0.60 |
| BECN1 | interacts_with | gene | 0.60 |
| GRK2 | interacts_with | gene | 0.60 |
| FOXO1 | interacts_with | gene | 0.60 |
| NR1H3 | interacts_with | gene | 0.60 |
| MAP3K5 | interacts_with | gene | 0.60 |
| SREBF2 | interacts_with | gene | 0.60 |
| NFE2L2 | interacts_with | gene | 0.60 |
| C1Q | interacts_with | gene | 0.60 |
| HTRA2 | interacts_with | gene | 0.60 |
| MTOR | interacts_with | gene | 0.60 |
| SIRT3 | interacts_with | gene | 0.60 |
| PLIN2 | interacts_with | gene | 0.60 |
| TP53 | interacts_with | gene | 0.60 |
| KDM6B | interacts_with | gene | 0.60 |
| SIRT1 | interacts_with | gene | 0.60 |
| STX17 | interacts_with | gene | 0.60 |
| STING1 | interacts_with | gene | 0.60 |
| GLP1R | interacts_with | gene | 0.60 |
| SREBF1 | interacts_with | gene | 0.60 |
| NOS3 | interacts_with | gene | 0.60 |
| LC3 | interacts_with | gene | 0.60 |
| SIRT1 | therapeutic_target | gene | 0.60 |
| TFEB | activates | gene | 0.60 |
| EIF2A | expressed_in | gene | 0.60 |
| RPTOR | interacts_with | gene | 0.60 |
| SQSTM1 | interacts_with | gene | 0.60 |
| PPARA | interacts_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Amino Acid Insufficiency | activates | phenotype | 0.95 |
| GCN2 | phosphorylates | gene | 0.90 |
| SESN1 | activates | gene | 0.85 |
| AICAR | activates | compound | 0.85 |
| Metformin | activates | drug | 0.85 |
| metformin | activates | drug | 0.85 |
| protein restriction | activates | process | 0.75 |
| PPARA | interacts_with | gene | 0.60 |
| ULK1 | interacts_with | gene | 0.60 |
| STX17 | interacts_with | gene | 0.60 |
| SQSTM1 | interacts_with | gene | 0.60 |
| NOS3 | interacts_with | gene | 0.60 |
| STING1 | interacts_with | gene | 0.60 |
| GLP1R | interacts_with | gene | 0.60 |
| SREBF1 | interacts_with | gene | 0.60 |
| SIRT1 | interacts_with | gene | 0.60 |
| KDM6B | interacts_with | gene | 0.60 |
| LC3 | interacts_with | gene | 0.60 |
| RPTOR | interacts_with | gene | 0.60 |
| FOXO1 | interacts_with | gene | 0.60 |
| TFEB | interacts_with | gene | 0.60 |
| MTOR | interacts_with | gene | 0.60 |
| P62 | interacts_with | gene | 0.60 |
| NR1H3 | interacts_with | gene | 0.60 |
| MAP3K5 | interacts_with | gene | 0.60 |
| LAMP2 | interacts_with | gene | 0.60 |
| BECN1 | interacts_with | gene | 0.60 |
| HTRA2 | interacts_with | gene | 0.60 |
| TFEB | activates | gene | 0.60 |
| SLC22A4 | expressed_in | gene | 0.60 |
| TLR4 | expressed_in | gene | 0.60 |
| EPHA4 | expressed_in | gene | 0.60 |
| PLIN3 | interacts_with | gene | 0.60 |
| PLIN2 | interacts_with | gene | 0.60 |
| C1Q | interacts_with | gene | 0.60 |
| NFE2L2 | interacts_with | gene | 0.60 |
| SIRT3 | interacts_with | gene | 0.60 |
| TP53 | interacts_with | gene | 0.60 |
| SIRT1 | therapeutic_target | gene | 0.60 |
| BECN1 | activates | entity | 0.60 |
| C1Q | activates | entity | 0.60 |
| FOXO1 | activates | entity | 0.60 |
| GLP1R | activates | entity | 0.60 |
| GRK2 | activates | entity | 0.60 |
| HTRA2 | activates | entity | 0.60 |
| KDM6B | activates | entity | 0.60 |
| LAMP2 | activates | entity | 0.60 |
| LC3 | activates | entity | 0.60 |
| MAP3K5 | activates | entity | 0.60 |
| MTOR | activates | entity | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||